The ROE as of December 2025 (TTM) for Intersect ENT, Inc. (XENT) is 15.52%

According to Intersect ENT, Inc.’s latest financial reports and current stock price. The company's current ROE is 15.52%. This represents a change of -86916.12% compared to the average of -17.88% of the last 4 quarters.

Intersect ENT, Inc. (XENT) Historical ROE (quarterly & annually)

How has XENT ROE performed in the past?

The mean historical ROE of Intersect ENT, Inc. over the last ten years is 2.91%. The current 15.52% ROE has changed 533.17% with respect to the historical average. Over the past ten years (40 quarters), XENT's ROE was at its highest in in the December 2021 quarter at 131.98%. The ROE was at its lowest in in the September 2021 quarter at -196.43%.

Intersect ENT, Inc. (XENT) ROE by Quarter and Year

Discovering the peaks and valleys of Intersect ENT, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Intersect ENT, Inc. (XENT) Average ROE

How has XENT ROE performed in the past?

The current ROE of Intersect ENT, Inc. (XENT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Intersect ENT, Inc. (XENT) ROE vs. Peers

How is XENT’s ROE compared to its peers?

Intersect ENT, Inc.’s ROE is greater than Cardiovascular Systems, Inc. (-14.19%), greater than Gracell Biotechnologies Inc. (-37.93%), greater than Paragon 28, Inc. (-26.80%), greater than Silk Road Medical, Inc (-35.39%), greater than Poseida Therapeutics, Inc. (-15.05%), greater than Albireo Pharma, Inc. (-84.83%), greater than Verve Therapeutics, Inc. (-35.82%), greater than Apollo Endosurgery, Inc. (-84.92%), greater than Harpoon Therapeutics, Inc. (-211.56%), greater than VectivBio Holding AG (-56.92%),

Build a custom stock screener for Intersect ENT, Inc. (XENT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intersect ENT, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intersect ENT, Inc. (XENT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intersect ENT, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.